Author Archives: biocon

Engineered natural killer cells may be the next great cancer immunotherapy

The cancer fighters known as CAR T cells have proved their prowess in recent years. Three therapies using the altered T cells against lymphoma or leukemia have won U.S. Food and Drug Administration approval, and hundreds of trials are now unleashing them on other malignancies, including solid tumors. Read more in sciencemag.org